Ambisome and Haemodialysis

This page shows results related to Ambisome and Haemodialysis from the FDA Adverse Event Reporting System (AERS).

Adverse Event

Safe Use Tools

Learn More

Comments

Ambisome and Haemodialysis

Age

>60 Years	10
40-49 Years	6
50-59 Years	5
10-19 Years	4
1-9 Years	1
20-29 Years	1

Gender

Male: 70%
Female: 30%

Outcome

What were the most common outcomes of those reporting Haemodialysis?

Hospitalization	16
Death	15
Other	15
Life Threatening	14
Disability	3

Reporter

Who most commonly reported Haemodialysis?

Physician	15
Other	12

Therapy

Of those reporting Haemodialysis, why were they taking Ambisome?

Bronchopulmonary Aspergillosis	9
Systemic Candida	6
Aspergillosis	4
Meningitis Cryptococcal	2
Fungal Infection	2

Other Medications

Which medications reported to the FDA are most commonly associated with Haemodialysis?

Metformin Hcl	428
Cyclosporine	255
Prograf	208
Metformin Hydrochloride	179
Mycophenolate Mofetil	175
	Show More
Prednisolone	148
Rapamune	145
Omniscan	128
Digoxin	123
Cytarabine	118
Methotrexate	116
Cyclophosphamide	104
Neoral	101
Ibuprofen	100
Simvastatin	100
Aspirin	94
Prednisone	92
Lithium Carbonate	89
Lisinopril	87
Etoposide	86
Velcade	85
Vancomycin	85
Tacrolimus	84
Methylprednisolone	84
Fabrazyme	82
Renagel	80
Valtrex	77
Acetaminophen	76
Ramipril	74
Vioxx	69
Zometa	68
Lipitor	67
Micardis	65
Cisplatin	65
Furosemide	64
Azathioprine	63
Metformin	62
Thymoglobulin	61
Aredia	54
Prednisone Tab	52
Enalapril Maleate	51
Diovan	51
Propofol	51
Dianeal	51
Allopurinol	51
Dexamethasone	50
Zocor	50
Amlodipine	49
Voltaren	49
Ciprofloxacin	48
Cellcept	47

Is the adverse drug reaction you’re experiencing actually due to the drug you took?

The Naranjo Scale is a questionnaire for determining the likelihood of whether an adverse drug reaction is actually due to the drug or caused by other factors. Probability is assigned via a score termed definite, probable, possible or doubtful.^*

	YES	NO	UNKOWN
Are there previous conclusive reports on this reaction?
Did the adverse event appear after the suspected drug was administered?
Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered?
Did the adverse reaction reappear when the drug was readministered?
Are there alternative causes (other than the drug) that could on their own have caused the reaction?
Did the reaction reappear when a placebo was given?
Was the drug detected in the blood (or other fluids) in concentrations known to be toxic?
Was the reaction more severe when the dose was increased, or less severe when the dose was decreased?
Did the patient have a similar reaction to the same or similar drugs in any previous exposure?
Was the adverse event confirmed by any objective evidence?

Probability of an Adverse Event

Doubtful

Possible

Probable

Definite

^*Naranjo, et al. "A method for estimating the probability of adverse drug reactions." Clin Pharmacol Ther. 1981 Aug;30(2):239-45.

To learn more about all adverse events for Ambisome, view the complete Ambisome adverse event report.

Scientific Publications on Haemodialysis

Comments

Share your experience with Ambisome and Haemodialysis.